Cellular manifestations of human papillomavirus infection in the oral mucosa

Journal of Surgical Oncology

Volumn 71, Issue 1, 1999, Pages 10-15

  Pillai, M Radhakrishna ^a   Phanidhara, A ^b   Kesari, A Lakshmi ^a   Nair, Pradip ^a   Nair, M Krishnan ^a  

^a REGIONAL CANCER CENTRE   (India)

^b SRI VENKATESWARA UNIVERSITY   (India)

Author keywords

Cyclin D1; Ki 67; p53; Tumor proliferation

Indexed keywords

CYCLIN D1; KI 67 ANTIGEN; ONCOPROTEIN; PROTEIN P53;

ARTICLE; CANCER MORTALITY; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; GENE INACTIVATION; GEOGRAPHIC DISTRIBUTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MOUTH CANCER; MOUTH INFECTION; MOUTH MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; VIRUS CARCINOGENESIS; VIRUS DETECTION; WART VIRUS;

CYCLIN D1; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KI-67 ANTIGEN; MOUTH MUCOSA; MOUTH NEOPLASMS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS;

EID: 0032982802     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199905)71:1<10::AID-JSO3>3.0.CO;2-V     Document Type: Article

References (24)

1. Jayanth K, Notani M: Epidemiology of oral cancer. In Rao RS, Desai PB (eds): "Oral Cancer," Bombay: Professional Education Division. Tata Memorial Hospital, 1991:1-7.
2. La Vecchia C, Tavani A, Franceschi S, et al.: Epidemiology and prevention of oral cancer. Oral Oncol 1997;33:302-312.
3. Sankaranarayanan R, Nair MK, Mathew B, et al.: Recent results of oral cancer research in Kerala, India. Head Neck 1992;14:107-112.
4. Lakshmi S, Nair AS, Pillai MR: Oral cancer and human papillomaviruses: Is there a link? J Surg Oncol 1993;52:193-196.
5. Park JS, Hwang ES, Park SN, et al: Physical status and expression of HPV genes in cervical cancers. Gynecol Oncol 1997;65:121-129.
6. Madrigal M, Janicek MF, Sevin BU, et al.: In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma. Gynecol Oncol 1997;64:18-25.
7. Turek LP, Smith EM: The genetic program of genital human papillomaviruses in infection and cancer. Obstet Gynecol Clin North Am. 1996;23:735-758.
8. Morrison EAB: Natural history of cervical infection with human papillomaviruses. Clin Infect Dis 1994;18:172-180.
9. Bruan L, Durst M, Mikumo R, et al.: Regulation of growth and gene expression in human papillomavirus-transformed keratinocytes by transforming growth factor β: Implications for the control of papillomavirus infection. Mol Carcinog 1992;8:100-111.
10. Sidransky D, Hollstein M: Clinical implications of the p53 gene. Ann Rev Med 1996;47:285-301.
11. Pillai MR, Lakshmi S, Sreekala S, et al.: High-risk human papillomavirus infection and E6 protein expression in lesions of the uterine cervix. Pathobiol 1998;66:240-246.
12. Ravi D, Nalinakumari KR, Rajaram RS, et al.: Expression of programmed cell death regulatory p53 and bcl 2 proteins in oral lesions. Cancer Lett 1996;105:139-146.
13. Kesari AL, Chellam VG, Madhavan J, et al.: Expression of the anti-apoptotic protein bcl-2 is not dependent on the tumor suppressor p53 protein in Indian breast carcinoma. Pathobiol 1997; 65:108-112.
14. Liang XH, Volkmann M, Klein R, et al.: Co-localization of the tumor suppressor protein p53 and human papillomavirus E6 protein in human cervical carcinoma cell lines. Oncogene 1993;8: 2645-2652.
15. Lechner MS, Mack DH, Finicle AB, et al: Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53 mediated repression of transcription. EMBO J 1992;11:3045-3052.
16. Mietz JA, Unger T, Huibregtse JM, Howley PM: The transcriptional transactivation function of wild type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO J 1992:11:5013-5020.
17. White E: Tumour biology. p53, guardian of Rb. Nature 1994;371: 21-22.
18. Pillai MR, Halabi S, McKalip A, et al.: The presence of Human Papillomavirus - 16/18 E6, p53 and bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer. Cancer Epidemiol Biomark Prevent 1996;5:329-335.
19. Matiashewski G: Human papillomavirus update - 15th Annual International Papillomavirus Workshop. Int J Cancer 1997:71:715-718.
20. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-331.
21. Lakshmi S, Nair BS, Jayaprakesh PG, et al.: p53 protein and tumorigenesis in the uterine cervix. Gen Diag Pathol 1997;142: 281-287.
22. Piffko J, Bankfalvi A, Torg K, et al.: Molecular assessment of p53 abnormalities at the invasive front of oral squamous cell carcinomas. Head Neck 1998;20:8-15.
23. Ravi D, Ramadas K, Mathew BS, et al.: De novo programmed cell death in oral cancer. Histopathol 1999 (in press).
24. Henson DE: Future directions for the American Joint Committee on Cancer. Cancer 1992;69:1639-1644.